233 related articles for article (PubMed ID: 16778210)
1. Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer.
Nam JS; Suchar AM; Kang MJ; Stuelten CH; Tang B; Michalowska AM; Fisher LW; Fedarko NS; Jain A; Pinkas J; Lonning S; Wakefield LM
Cancer Res; 2006 Jun; 66(12):6327-35. PubMed ID: 16778210
[TBL] [Abstract][Full Text] [Related]
2. Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model.
Sato M; Matsubara T; Adachi J; Hashimoto Y; Fukamizu K; Kishida M; Yang YA; Wakefield LM; Tomonaga T
PLoS One; 2015; 10(5):e0126483. PubMed ID: 25993439
[TBL] [Abstract][Full Text] [Related]
3. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD
Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703
[TBL] [Abstract][Full Text] [Related]
5. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
6. Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells.
Tu Q; Zhang J; Fix A; Brewer E; Li YP; Zhang ZY; Chen J
J Cell Physiol; 2009 Jan; 218(1):135-45. PubMed ID: 18756497
[TBL] [Abstract][Full Text] [Related]
7. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells.
Barnes GL; Javed A; Waller SM; Kamal MH; Hebert KE; Hassan MQ; Bellahcene A; Van Wijnen AJ; Young MF; Lian JB; Stein GS; Gerstenfeld LC
Cancer Res; 2003 May; 63(10):2631-7. PubMed ID: 12750290
[TBL] [Abstract][Full Text] [Related]
8. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
[TBL] [Abstract][Full Text] [Related]
9. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.
Muraoka RS; Dumont N; Ritter CA; Dugger TC; Brantley DM; Chen J; Easterly E; Roebuck LR; Ryan S; Gotwals PJ; Koteliansky V; Arteaga CL
J Clin Invest; 2002 Jun; 109(12):1551-9. PubMed ID: 12070302
[TBL] [Abstract][Full Text] [Related]
10. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta 1 regulation of bone sialoprotein gene transcription: identification of a TGF-beta activation element in the rat BSP gene promoter.
Ogata Y; Niisato N; Furuyama S; Cheifetz S; Kim RH; Sugiya H; Sodek J
J Cell Biochem; 1997 Jun; 65(4):501-12. PubMed ID: 9178100
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of IFN-gamma B7.1 and antisense TGF-beta gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma.
Wu RS; Kobie JJ; Besselsen DG; Fong TC; Mack VD; McEarchern JA; Akporiaye ET
Cancer Immunol Immunother; 2001 Jul; 50(5):229-40. PubMed ID: 11499806
[TBL] [Abstract][Full Text] [Related]
13. Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice.
Sharp JA; Waltham M; Williams ED; Henderson MA; Thompson EW
Clin Exp Metastasis; 2004; 21(1):19-29. PubMed ID: 15065599
[TBL] [Abstract][Full Text] [Related]
14. Amelogenin stimulates bone sialoprotein (BSP) expression through fibroblast growth factor 2 response element and transforming growth factor-beta1 activation element in the promoter of the BSP gene.
Shimizu E; Saito R; Nakayama Y; Nakajima Y; Kato N; Takai H; Kim DS; Arai M; Simmer J; Ogata Y
J Periodontol; 2005 Sep; 76(9):1482-9. PubMed ID: 16171436
[TBL] [Abstract][Full Text] [Related]
15. Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β.
Parvani JG; Galliher-Beckley AJ; Schiemann BJ; Schiemann WP
Mol Biol Cell; 2013 Nov; 24(21):3449-59. PubMed ID: 24006485
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of bone sialoprotein silencing on the adhesion ability of breast cancer cells to bone matrix].
Wang L; Wang J; Yang D; Yang C; Xia B; Wang J; Xian J
Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):233-9. PubMed ID: 21650048
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
[TBL] [Abstract][Full Text] [Related]
18. Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells.
Gordon JA; Sodek J; Hunter GK; Goldberg HA
J Cell Biochem; 2009 Aug; 107(6):1118-28. PubMed ID: 19492334
[TBL] [Abstract][Full Text] [Related]
19. An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer.
Rausch MP; Hahn T; Ramanathapuram L; Bradley-Dunlop D; Mahadevan D; Mercado-Pimentel ME; Runyan RB; Besselsen DG; Zhang X; Cheung HK; Lee WC; Ling LE; Akporiaye ET
Anticancer Res; 2009 Jun; 29(6):2099-109. PubMed ID: 19528470
[TBL] [Abstract][Full Text] [Related]
20. Mouse models of transforming growth factor beta impact in breast development and cancer.
Serra R; Crowley MR
Endocr Relat Cancer; 2005 Dec; 12(4):749-60. PubMed ID: 16322320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
